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Applied Sciences, Harvard University, Cambridge, MassachusettsABSTRACT The concerted action of a large number of individual molecular level events in the formation and growth of fibrillar
protein structures creates a significant challenge for differentiating between the relative contributions of different self-assembly
steps to the overall kinetics of this process. The characterization of the individual steps is, however, an important requirement for
achieving a quantitative understanding of this general phenomenon which underlies many crucial functional and pathological
pathways in living systems. In this study, we have applied a kinetic modeling approach to interpret experimental data obtained
for the aggregation of a selection of site-directed mutants of the protein S6 from Thermus thermophilus. By studying a range of
concentrations of both the seed structures, used to initiate the reaction, and of the soluble monomer, which is consumed during
the growth reaction, we are able to separate unambiguously secondary pathways from primary nucleation and fibril elongation.
In particular, our results show that the characteristic autocatalytic nature of the growth process originates from secondary
processes rather than primary nucleation events, and enables us to derive a scaling law which relates the initial seed concen-
tration to the onset of the growth phase.INTRODUCTIONThe level of interest focused on understanding the assembly
and structure of nanoscale protein fibrils has increased
significantly in the last decade due to the realization that
the formation of amyloid fibrils is intricately associated
with a range of neurodegenerative disorders, including
Parkinson’s (1) and Alzheimer’s diseases (2–5), and other
medical conditions including type II diabetes. The under-
lying similarities in the structures and behavior of protein
fibrils found in connection with apparently disparate disor-
ders, together with the finding that many proteins, both
with and without connection to disease, are able to undergo
fibrillar assembly in vitro, has led to the idea that the
amyloid state represents a generally accessible alternative
form of organized protein structure (6,7).
Despite the apparent simplicity associated with the
description of amyloid growth as a homomolecular assem-
bly phenomenon, it has become apparent that this process
is characterized by a remarkable degree of complexity on
the molecular level, and that many different molecular
events contribute to the overall assembly pathway. It is
widely agreed that fibril formation is initiated by a primary
nucleation step (8) wherein soluble proteins come together
to form aggregates capable of subsequent growth through
incorporation of further species and leading to elongation
of the structures when they acquire fibrillar character
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mers rather than oligomers, a conclusion in agreement
with the finding that fibril growth can be observed under
conditions where no significant oligomer populations can
be detected (10,14) and the fact that the elongation of fibrils
has been found to be directly proportional to the concentra-
tion of soluble protein (10,11).
A crucial characteristic of such fibrillar assembly
phenomena is the sigmoidal nature of the reaction profile:
the rate of assembly accelerates during the first part of the
process, and then slows down to reach an equilibrium end-
point that results from the depletion of available protein in
solution. The origin of the acceleration in the reaction rate
for early times is, however, still a topic of investigation
and discussion. It is important to note that, if the number
of fibril ends present in solution remains constant, the rate
of the overall conversion of soluble protein into the fibrils
will be linear in the monomer concentration because the
growth occurs primarily at the ends of the fibrils. A higher
than linear concentration dependence requires, therefore,
the multiplication of such fibrils in number in order to
increase the number of ends where the growth occurs
(15–17). This type of proliferation in the number of fibrils
in some studies has been attributed to further primary nucle-
ation, where new fibrils emerge from soluble protein in
parallel to the growth of existing fibrils, but in others to
secondary pathways, where additional growth centers are
formed from growing fibrils, e.g., by fibril breakage,
surface-catalyzed nucleation, or branching (see (15,18,19)
for a more detailed description of secondary pathways).
In the literature, the term ‘‘fibril growth’’ is commonly
used to indicate both fibril elongation and multiplication,doi: 10.1016/j.bpj.2012.03.047
2168 Lorenzen et al.and combinations of such processes; relatively little work
has focused on the challenge of identifying the true contri-
bution of the elongation process relative to the contributions
of primary and secondary nucleation. Indeed, parameters in
empirical sigmoidal functions, such as the logistic function
(14), combine both microscopic rates into phenomenolog-
ical parameters such as the lag-time or the apparent
maximal growth rate. A further complication results from
the fact that the relative populations of different types of
fibrils and their structures can be shifted dramatically
upon changes in the environment (20,21). This changing
picture of fibril polymorphism can, however, be avoided
by seeding with preformed fibrils, thereby templating the
subsequent growth of one fibril type without the requirement
for primary nucleation.MATERIALS AND METHODS
General notes
All S6 mutants were expressed recombinantly, purified, and dialyzed
against deionized water as described previously in Otzen et al. (22). Protein
concentrations were determined by absorption at 280 nm using an ND-1000
spectrophotometer (NanoDrop, ThermoScientific, Wilmington, DE). A
theoretical extinction coefficient at 12.700 cm1, M1 was used. Fibril
formation was carried out in 10 mM HCl (pH 2), 0.4 M NaCl at 42C
with agitation (900 rpm during seed formation and 180 rpm in plate reader
experiments). All Thioflavin T (ThT) fluorescence measurements were
performed in triplicate.Asymmetric flow field-flow fractionation
Here, we used asymmetric flow field-flow fractionation (AF4). Samples of
100 mM S6 VA88 were harvested from the kinetic plate reader experiments
over a period of five days and centrifuged at 13,400 rpm for 15 min in
a MiniSpin centrifuge (Eppendorf, Hamburg, Germany). A 100-mL sample
was injected onto an AF2000 asymmetrical flow field-flow fractionation
system (Postnova, Landsberg, Germany) equipped with an S3240 UV/Vis
detector monitoring absorbance at 205 and 280 nm, PN3140 refractive
index, and a PN3070 7-angle light scattering detector. The system was
equipped with a 5-kDa MWCO ultrafiltration membrane and a 350-mm
spacer, and was equilibrated in 10 mM HCl (pH 2), 0.4 M NaCl at room
temperature. The sample was separated, injected, and focused for 5 min
at 0.2 mL/min with a focus flow of 2.3 mL/min and cross-flow of 2 mL/min.
The detector flow was kept constant at 0.5 mL/min throughout the injection,
focusing, and separation. After focusing, a cross-flow gradient from 2 to
0.15 mL/min over 20 min followed by a 10-min gradient to 0 mL/min
was applied to separate potential S6 species. The system was then washed
at 0 mL/min cross-flow for 15 min.Seed formation
Mature fibrils were prepared in 1.5 mL test tubes containing 100–250 mMof
S6 under fibril forming conditions and incubated in a Vortemp 56 evc.
Eppendorf shaker (Tehtnica, Zĕlezniki, Slovenia). Fibril formation was
followed using ThT fluorescence: samples were diluted 12 times with a
ThT solution (40 mM ThT final, 10 mM HCl, pH 2, 10 mMNaCl) and incu-
bated for 10 min in an Eppendorf shaker under conditions identical to those
used for fibril growth. Fluorescence measurements were carried out on
a LS55 Luminescence spectrometer (Perkin-Elmer, Norwalk, CT) using
emission and excitation slit widths of 10 nm, excitation at 450 nm, andBiophysical Journal 102(9) 2167–2175emission at 465–555 nm. Seeds were obtained by sonication on ice of
mature fibrils using a HD 2070 Bandelin Sonuplus Sonicator (Buch &
Holm, Copenhagen, Denmark) for three times,1 min, at 60% power. Seeds
were kept at 4C.Fibril formation kinetics with platereader
Seeded fibril growth from different mutant variants was monitored using
ThT-fluorescence (using excitation at 450 nm and emission at 485 nm)
performed every 20 min on a GENios Pro Plate Reader (TECAN, Ma¨nne-
dorf, Germany) in 96-well plates. All samples contained 40 mMThT, 10mM
HCl (pH 2), 0.4 M NaCl. The temperature was kept at 42C, shaking
was linear at 180 rpm, and shaking duration was 3 min in every 20-min
cycle.Atomic force microscopy
For analysis by atomic force microscopy (AFM), mature fibrils and seed
samples were prepared as described above from a 100 mM S6 monomer
solution. 5 mL sample aliquots were deposited on freshly cleaved mica
(SPI supplies, West Chester, PA). Samples were imaged by AFM, under
ambient conditions at room temperature, using a NanoWizard II
(JPK Instruments, Cambridge, UK) and Ultrasharp NSC36 cantilevers
(MikroMasch, Tallinn, Estonia) in contact mode at a line rate of 1.5 Hz
and a resolution of 512  512 pixels. Images were analyzed with the
open source software Gwyddion (http://gwyddion.net/).Fourier transform infrared spectroscopy
Fourier transform infrared spectroscopy (FTIR) spectra of fibrils and mono-
meric solutions were obtained with a Tensor 27 FT-IR (Bruker Optics,
Billerica, MA). Spectra were accumulations of 68 scans, measured with
a resolution at 2 cm1 in the range from1000 to 3998 cm1. Data processing,
consisting of atmospheric compensation, baseline subtraction, and fitting
with Lorentzian curves, was performed with the software OPUS ver. 5.5
(http://www.stsci.edu/software/OPUS/kona2.html). For the comparison of
seed and second-generation fibrils, spectra were normalized.Transmission electron microscopy
Transmission electron microscopy (TEM) was carried out as described
previously in Pedersen et al. (20). Briefly, a 5-mL aliquot (50–100 mM
S6, incubated as above) was placed on a 400-mesh, carbon-coated, glow-
discharged grid for 30 s. Grids were washed in two drops of double-
distilled water and stained with 1% (w/v) phosphotungstic acid at pH 6.8
and blotted dry on filter paper. Samples were viewed with a model No.
1010 transmission electron microscope (JEOL, Peabody, MA) at 25,000
magnification.RESULTS AND DISCUSSION
In order to identify the effects of fibril elongation and
secondary pathways relative to other processes contributing
to the overall fibril growth process, we can analyze system-
atic variations in the growth kinetics that result from
changes in the quantities of preformed aggregates that are
added and of monomer. We illustrate this approach in this
article by studying members of a library of single and
double mutants of the ribosomal protein S6 from Thermus
thermophilus. The protein S6 has emerged as an outstanding
S6 Fibril Growth 2169system for probing protein folding (22–24) and aggregation
(20). Under acid-denaturing conditions which promote fibril
formation (0.4 M NaCl, 10mM HCl (pH 2), 42C), the
native state of S6 (N) is destabilized and the protein can
undergo amyloid assembly. The choice of S6 as the system
of study in this work also gives rise to a key advantage, in
that the primary nucleation of amyloid structures from S6
monomers is slow under these conditions (Fig. 1), providing
a window within which it is possible to study elongation and
multiplication of fibrillar species in the knowledge that
primary nucleation is not contributing significantly to the
evolution of observed fibrillar structures.
By the use of preseeding, hence avoiding the effects of
polymorphism, within this window where primary nucle-
ation does not contribute significantly to the fibril popula-
tion, we reduce the number of variables that need to be
defined in the self-assembly reaction. We confirmed directly
that no oligomers were present in our preseeded experi-
ments using AF4, AFM, and TEM measurements (see the
Supporting Material). We can then use an array of different
S6 mutants to span a broad range of fibril formation kinetics
to test the validity of our model over an extended parameter
range. The fibril kinetics are followed using in situ ThT
fluorescence measurements; we have previously shown by
electron microscopy that S6 fibrils formed under these
conditions lead to high ThT signals (25).
Initial examination of the data describing fibril kinetics
reveals that there is a difference between the ThT signal
given from pregrown seeds and fibril material that formsFIGURE 1 Kinetic traces for the fibril formation of S6 protein (LA30)
with and without the initial addition of seeds of preformed fibrils. In the
absence of such seed material (lower trace), no fibrillar material is detected
over the time course of 80 h. With the addition of preformed seeds (upper
trace), however, all monomer is incorporated into aggregates within this
time window. Hence, the sigmoidal rate profile that is observed in this
case unambiguously reflects the role of secondary pathways. In addition,
the preseeded trace demonstrates the different scaling of the ThT fluores-
cence signal with initial seed material and the new material formed during
the reaction, as given by Eq. 1. The system had initial seed concentration
8.3 mM and initial monomer concentration 100 mM. The ratio of the total
monomer concentration in the system, 108.3 mM, to the initial seed concen-
tration, 8.3 mM, is ~13, yet the ratio of the final/initial signal reported by
ThT is ~24.in the reaction through addition to the seeds, although the
structures of seeds and fibrils grown from seeds are very
similar when compared using FTIR and AFM measure-
ments (see the Supporting Material). In other words, the
observed ThT signal obeys a dependency of the form
Signal ¼ rMinitial seeds þ sMnew material
¼ rMð0Þ þ s½MðtÞ Mð0Þ
; (1)
where M denotes the concentration of monomer in aggre-
gates, r is fixed so that the seed concentration is reported
correctly at the beginning of the reaction, and s is fixed
so that the total monomer concentration is defined correctly
at the end of the reaction. This effect can be seen in
Fig. 1 where the initial seed concentration is 8.3 mM and
the initial monomer concentration is 100 mM. The ratio of
the final/initial ThT signal is ~24, whereas the ratio of total
monomer to monomer initially in seeds is ~13, implying
s z 2r.Elongation
The time evolution of a population of fibrillar species
proliferating through primary nucleation, elongation, and
secondary pathways has been studied extensively over the
past 40 years (16–18,26–28). Much work has focused on
integrated rate laws valid for the early stages of the reaction
(10,15,18,29–31), first derived in the pioneering work of
Ferrone et al. (18,32) in their studies of sickle hemoglobin
gelation; more recently these solutions have been extended,
using a self-consistent approach, to give integrated rate
laws valid for the entire reaction time course (16,17,33).
Solutions valid over the entire reaction will be vital in
studying secondary nucleation later in this article, whereas
the early time behavior is related to elongation in this
section.
The early stages of aggregation in the S6 system can be
used to study unambiguously the elongation of fibrillar
species. We focused first on the effect of seed concentration
on the addition of monomeric protein to fibrillar species in
the initial stages of the reaction. For a system where primary
nucleation does not contribute significantly to the fibril
population, and for which preformed seeds are instead
used to initiate the reaction, the fibrillar mass-concentration,
M(t), evolves in the initial stages of the reaction according
to (17),
MðtÞ ¼ mð0ÞCþekt  mð0ÞCekt; (2)
t/0 ~

2
¼ Mð0Þ þ 2kþmð0ÞPð0Þt þO t ; (3)
where P(t) denotes the number-concentration of fibrils and
m(t) denotes the free monomer concentration. The constants
in Eq. 3 are given asBiophysical Journal 102(9) 2167–2175
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ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2~kþk2mð0Þn2
q
C5 ¼
~kþPð0Þ
k
5
Mð0Þ
2mð0Þ:
(4)
The kinetic rate constant for elongation from each end is
~given as kþ and that for the secondary pathway by k2. The
elongation rate constant in this formulation, ~kþ, may not
be independent of the monomer concentration; we discuss
this later in this section. The parameter n2 describes the
monomer-dependence of the secondary pathway such that
n2 ¼ 0 corresponds to the monomer-independent case of
fragmenting filaments (15,16,18,27,34,35); a nonzero value
of n2 represents a monomer-dependent secondary pathway,
for example, where the surface of existing filaments is active
in catalyzing the formation of new growth nuclei
(15,18,33,36). Equation 3 shows that, for early times, the
secondary pathway is less important in defining the overall
consumption of free monomer m(t) than the direct elonga-
tion of fibrils proportional to 2~kþmð0Þ.
Equation 3 shows that for kinetic data describing seeded
growth, the intercept is the initial seed concentration M(0)
and the initial reaction rate r0 is given as
r0 ¼ dM
dt

t/0
¼ 2~kþmð0ÞPð0Þ: (5)
For systems of fixed initial monomer concentration and
varying initial seed concentration, Eq. 5 shows that the
initial gradients are expected to be proportional to the initial
seed number-concentration, P(0), and the intercept to be
proportional to the initial seed mass-concentration, M(0).
The mass concentration of seeds added to the system is
known for all of our data, and for a given seed preparation
used to preseed a series of experiments, the seed number
concentration is linked to the seed mass concentration
through the average seed length in the preparation, hL(0)i,
so that P(0) ¼ M(0)/ hL(0)i. Therefore, the intercept andA B
FIGURE 2 Scaling of the intercept and initial gradient with a varying initial s
Eqs. 3 and 5. (A) Example of raw data (using VA37) for the early-time evolution o
slope of the initial linear growth phase shows a linear dependency with the seed c
linear phases also reveal a linear dependency on the seed concentration. The fixed
for the variants AG35 (circle), IA8 (square), and VA37 (diamond).
Biophysical Journal 102(9) 2167–2175initial gradient are both expected to vary linearly with the
seed mass-concentration. These predictions are validated
in the scaling behavior seen in the data for a range of
mutants in Fig. 2.
The separation of fibril elongation from primary nucle-
ation and secondary pathways, as described above, provides
an opportunity to investigate the sensitivity of fibril elonga-
tion toward single and double mutations. The final (plateau)
fluorescence intensities in the experiments, at a given mono-
mer concentration, vary by significantly less than one order
of magnitude, showing that the changes in the initial fluores-
cence intensity reflect principally changes in the intrinsic
elongation rates rather than variation in ThT binding affinity
or degree of fluorescence enhancement. Under this assump-
tion, the elongation rates for a range of mutant/seed combi-
nations have been evaluated and are shown in Table 1. This
assumption is further confirmed by noting that the relative
elongation rates when WTand LA30/VA65 seeds are grown
with monomeric IA8 (2.8 and 4.5, respectively) and mono-
meric LA61 (0.2 and 0.4, respectively) result in very similar
ratios of the elongation rates of 0.6 (2.8/4.5) and 0.5
(0.2/0.4) (Table 1).
This finding reflects the dominant role of the protein that
is converted into its aggregated form rather than the nature
of the seed in defining the elongation rate of amyloid fibrils
(37,38). In an earlier study, we have reported that single and
double mutants of S6 strongly affect the primary nucleation
rate (20). Our study clearly demonstrates that the elongation
rate is highly affected by single and double mutations, even
in the case of conservative mutations. A search performed
for correlations between the elongation rates found with
WT seed (Table 1) and the corresponding physico-chemical
properties of the mutants did not reveal significant trends
between the elongation rate and the folding parameters
(unfolding rate constant ku, refolding rate constant kf, and
melting temperature Tm; (20) and data not shown). This
finding indicates that factors other than the thermodynamic
stability of the folded state relative to unfolding control theC
eed concentration at a fixed initial monomer concentration as predicted by
f the polymer mass at increasing seed concentration (bottom to top). (B) The
oncentration. (C) The intercepts obtained from linear regression of the initial
monomer concentration was 100 mMand the data (both seed and monomer)
TABLE 1 Data for the linear variation of the initial gradient of
fibril growth with seed concentration at a fixed monomer
concentration
Seed species
Monomer
species vr0/vM(0)
Correlation
coefficient
Nominal relative
elongation rate
WT YA63 70.7 0.98 1.0
WT LA75/MA67 154.9 0.97 2.2
WT LA30 246.9 0.99 3.5
WT AG35 103.5 0.99 1.5
WT IA8 194.6 0.98 2.8
WT VA37 267.6 0.99 3.8
WT LA61 14.1 0.99 0.2
WT IA8/LA26 25.1 0.98 0.4
LA30/VA65 IA8 319.8 0.99 4.5
LA30/VA650 LA61 29.7 0.99 0.4
Gradients determined from linear regression analysis, vr0/vM(0), equivalent
to those of the fitted lines shown in Fig. 2, are tabulated. Data are shown for
a range of seed/monomer mutant combinations at fixed monomer concen-
tration (100 mM). The correlation coefficient from the linear fits, R, is given
in the table. The final column gives the relative elongation rates that can be
extracted as the ratios of the gradients of the linear regressions as discussed
in the text.
S6 Fibril Growth 2171changes in the elongation rates of the S6 mutant variants.
Indeed, mutations can affect parts of the energy landscape
that relate to the formation of inter- rather than intramolec-
ular contacts which are involved in amyloid fibril growth but
not the unfolding of a single chain.
Considering now the complementary case of systems
with a fixed initial seed concentration and varying initial
monomer concentration, Eq. 5 shows that, if ~kþ is indepen-
dent of the monomer concentration, the theory predicts
that the initial gradient will be proportional to the total
monomer concentration; indeed, the fibril elongation rate
is given as
velongationt MðtÞ ¼ 2~kþmðtÞPðtÞ:
At high monomer concentrations, however, diffusion of
monomers to the fibril ends is no longer rate-limiting;
instead, the structural reorganization of the polypeptide
chain subsequent to its initial attachment to a fibril end takes
over this role. For the overall elongation step, therefore, the
rate exhibits a concentration dependence (10,39,40), which
is analogous to that of the Michaelis-Menten scheme (41)
for enzymatic reactions,
r0 ¼ 2~kþmð0ÞPð0Þ ¼ 2kþmð0Þ
1þ K1m mð0Þ
Pð0Þ; (6)
where kþ is a true elongation rate constant that is indepen-
FIGURE 3 Saturation of the initial gradient of fibril growth at high
monomer concentration as prediction by Eq. 6. By varying the initial mono-
mer concentration at a fixed initial seed concentration, we identify clearly
the predicted saturation in the initial gradient corresponding to the transi-
tion from diffusion to conformational-rearrangement limited fibril elonga-
tion discussed in the text, in Eq. 6; the line is a fit to this predicted form.
The seed concentration is 8.3 mM. The data shown are for IA8 seed and
monomer.dent of the monomer concentration, and Km is the crossover
concentration above which elongation is rearrangement-
limited. This form emerges naturally from the landscape
model of protein folding (39), without the requirement to
assume two discrete steps in the overall conversion process.
It is interesting to note that the elongation rate constant kþ,
which is partially determined by the probability of successof a given encounter between a monomer and a fibril end,
is expected to be highly dependent on changes in reaction
conditions, point mutations, etc.; the crossover concentra-
tion, Km, may be less effected by such changes (39). Differ-
ences in r0 between S6 mutants could be expected to
reflect, therefore, primarily changes in the elongation rate
constant kþ. For lower monomer concentrations such that
Km
1m(0)  1, Eq. 6 reduces ~kþ ¼ kþ and the reaction
rate increases linearly with the total monomer concentra-
tion. However, for very high monomer concentrations
such that Km
1m(0)[ 1, Eq. 6 shows that the initial rate
of incorporation of monomers into fibrils saturates and no
longer possesses a concentration dependence. The data
shown in Fig. 3 show that the elongation rate increases
with the concentration of monomer for lower concentrations
before becoming saturated at higher monomer concentra-
tions, as predicted by the theory.Secondary pathways
We now turn to the analysis of the lag-phase in order to iden-
tify the role of secondary pathways in the fibrillation reac-
tion. The existence of a lag-phase in a system where
primary nucleation does not make a significant contribution
to the increase in the number of fibrils or their mass over the
time course of the experiment is direct evidence for the
presence of a fibril-dependent secondary pathway respon-
sible for the proliferation of fibrils, and has previously
provided support for the role of filament fragmentation in
prion propagation (42) and lateral growth in the aggregation
of glucagon (43). Indeed, for seeded growth in the absence
of a secondary pathway, it is not possible to observe a
lag-phase (17,44). In systems which exhibit a significant
contribution from primary nucleation, the identification ofBiophysical Journal 102(9) 2167–2175
2172 Lorenzen et al.secondary pathways is more complicated. Indeed, it is in
general difficult to establish under such conditions what
fraction of the bulk kinetic behavior can be attributed to
secondary pathways, and what fraction may originate
instead from potentially very complex, and possibly incom-
pletely understood, primary nucleation pathways. This
problem does not exist with the system studied in this
work and the results represent a striking example of a system
where secondary pathways alone lead to a very clear
sigmoidal rate profile.
We see in Fig. 1 that in the S6 system, primary nucleation
does not generate a significant fibril population over the
timecourse shown. However, upon addition of initial seed
material, we are able to observe fibril formation within
this window, and moreover the reaction follows a sigmoidal
rate profile. The measurement of this rate profile, where
without the influence of primary nucleation the reaction
rate nevertheless initially accelerates even as the monomer
is depleted, provides an unambiguous and striking identifi-
cation of the role of secondary pathways in S6 aggregation.
We can analyze our data further within the standard
framework of filamentous growth through elongation and
secondary pathways (16–18,26,27,34). In a previous anal-
ysis (16), closed-form analytical solutions to the rate equa-
tions for filament assembly that are valid for the entire
reaction time course were derived using a self-consistent
approach to extend the validity of the well-known linearized
solution (15,18,29); see Eq. 2. Interestingly, within this
theoretical framework it has been shown (16) that for
a constant initial monomer concentration and varying initial
seed concentration, the time for the reaction to reach half-
completion, t50%, varies logarithmically with the initial
seed concentration, M(0):FIGURE 4 Effect of the saturation of the elongation rate on the time course of
rate equations (29,18,15). (A) Time course computed numerically (17) (solid line
linearly on the monomer concentration (16). In this case, the linearized solution
time course. A self-consistent solution has been derived previously that is accu
numerically (17) (solid line) for the casewhere the elongation rate is saturated (39
earity in the rate equations (17) is reduced, increasing the range of validity of the l
the seed concentration calculated numerically for the cases shown in panels A
found. In panel A, ~kþ ¼ kþ with kþ ¼ 5 $ 103 kþ ¼ 1 M1 s1; in panel B, ~kþ ¼
For panelsA andB, the other parameters are:m(0)¼ 50mM, k¼ 2 $ 109 s1, kn
from panel A (shaded) and panel B (solid), respectively, except for the varying se
Biophysical Journal 102(9) 2167–2175t50%fconst logðMð0ÞÞ: (7)
This result was derived (16) in the regime where the elonga-
tion rate is proportional to the monomer concentration,
~kþ ¼ kþ; the self-consistent solution (16,17) is required
to derive Eq. 7 in this case because the previously known
linearized form, Eq. 2, is no longer valid at the half-time
(Fig. 4 A). It is interesting to note that in the opposite
regime, where the elongation rate is saturated and no longer
depends on the monomer concentration, m(0)  Km, the
nonlinearity of the rate laws (17,18,29) is reduced signifi-
cantly, resulting in the linearized solution (Eq. 2), having
extended validity. For the low values of n2 % 4 typically
observed for amyloid formation (10,16,36), the linearized
solution has validity, in the case where the elongation rate
is saturated, that extends to the time to half-completion
(Fig. 4 B). In this case, inversion of the linearized rate law
(Eq. 2) predicts also a scaling relationship (15,18,42) for
the half-time identical to Eq. 7. Therefore, the scaling law
Eq. 7 has general validity independent of whether the elon-
gation rate is saturated or not, as verified in Fig. 4 C.
This scaling from Eq. 7 is observed clearly in our data in
Fig. 5. The decrease in lag-time with increasing initial seed
concentration can be explained by noting that with a higher
seed concentration the incorporation of monomers through
elongation is accelerated, and also that concordantly the
number of bonds and the surface area of fibrillar species
in the system increases faster, resulting in secondary path-
ways being active at an earlier time.
An additional feature characteristic of the aggregation of
S6 is the pronounced transition from the early phase linear
growth into the late stage sigmoidal growth at a finite time
after the beginning of the reaction. In order to gain insightthe reaction, and comparison with the well-known linearized solution to the
) for the aggregation reaction for the case where the elongation rate depends
(dotted line), from Eq. 2, is only accurate for the early part of the reaction
rate for the full time-course in this case (16). (B) Time-course computed
) and does not depend on themonomer concentration. In this case, the nonlin-
inearized solution (dotted line), from Eq. 2. (C) Scaling of the half-timewith
(solid) and B (shaded). In both cases a logarithmic scaling, from Eq. 7, is
kþ=½1þ mð0Þ=Km with Km ¼ m(0)/10 and kþ ¼ 1 $ 104 kþ ¼ 1 M1 s1.
¼ 0, n2¼ 0,M(0)¼m(0)/100, andP(0)¼M(0)/5000. PanelC has parameters
ed (mass) concentrations shown.
FIGURE 5 Logarithmic scaling of the time to half-completion of the
fibril formation reaction with the initial seed concentration as predicted
by Eq. 7; the data are extracted from the traces shown in Fig. 4. (Solid
circles) Monomer LA75/MA67 in solution and added seed from LA30/
VA65, with a fixed initial monomer concentration 80 mM. (Shaded squares)
Monomeric LA30 and WT seed, with a fixed initial monomer concentration
of 100 mM.
S6 Fibril Growth 2173into this behavior, we first consider the case where the elon-
gation rate is linear in the concentration of monomeric
peptide, ~kþ ¼ kþ. It is possible to derive the expected
dependency of this characteristic time to onset on the initial
seed concentration, because the initial gradient and the
maximum gradient are known (17). By solving for the inter-
cept of these two straight lines Mearly(t) and Mgrowth(t)
(Fig. 6 a), we find the time to onset, ton, given from the
condition Mearly(ton) ¼ Mgrowth(ton), where
MearlyðtÞ ¼ Mð0Þ þ 2kþmð0ÞPð0Þt; (8)
mð0Þk log

C1
þ 1
MgrowthðtÞ ¼
e
t  þ
e
þ 1; (9)
yielding
  ton ¼
e Mð0Þ þ mð0Þ 1 eþ log C1þ
½k 2ePð0Þkþ mð0Þ : (10)FIGURE 6 Logarithmic scaling of the time to onset of the growth phase with t
the growth phase is defined as the time at the intercept of the straight linesMearly
this way. The data are for monomer LA30 with WT seed with a fixed monomer
best fit to the predicted form, from Eq. 11.The condition for the existence of a lag-phase is k [
2eP(0)kþm(0) (17), and so for low seed concentrations,
M(0)m(0), the result reduces in this limit to an equivalent
logarithmic relation to that found for the time to half-
completion:
tonfconst logðMð0ÞÞ: (11)
This result has been derived for the case where the elonga-
tion rate depends linearly on the monomer concentration
(16,17); an identical result emerges in the case where the
elongation rate is saturated, through the use of the linearized
solution (Eq. 2), as discussed for Fig. 4. The scaling result,
Eq. 11, is applied to our measurements in Fig. 6 where the
predicted scaling is observed. It is interesting to note that
in the other limiting situation where no lag-phase exists,
k  2eP(0)kþm(0), the full relationship Eq. 10 returns the
scaling law t ~ 1/P(0), a finding consistent with the solution
M(t) ~ e2kþPð0Þt in this limit.
Interestingly, the effects of mutations in the sequence of
S6 on the fibril elongation rate also imply changes in the
time to the onset of the growth phase. Indeed, Eq. 10 shows
that this time is, to first-order, inversely proportional to the
parameter k which contains a dependency on the elongation
rate k ~ kþ
1/2. In agreement with this deduction, WT seed
with monomeric mutant YA63, which has a low relative
elongation rate (1.0; Table 1), was found not to reach the
growth phase during the time course of 100 h, whereas
substituting mutant LA75/MA67 as monomer (relative
elongation rate 2.2; Table 1) resulted in a shorter time to
the growth phase, and substituting mutant LA30 as mono-
mer (relative elongation rate 3.5; Table 1) resulted in a still
further decrease in the observed time to onset.CONCLUSIONS
In conclusion, the analysis of the aggregation behavior of
a selection of site-directed mutants of the model protein
S6 from Thermus thermophilus has enabled us to separate
unambiguously the action of secondary pathways fromhe initial seed concentration as predicted by Eq. 11. (A) The time to onset of
(t) andMgrowth(t) shown. (B) Extraction of the characteristic time defined in
concentration 100 mM. (C) The predicted logarithmic scaling with a line of
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2174 Lorenzen et al.that of primary nucleation and that of fibril elongation.
Because multiple processes contribute to the rate of the
overall growth reaction, we employed an approach whereby
a given system parameter, here the seed concentration, was
varied systematically while keeping the others constant.
Furthermore, our results show that the generation of new
fibrils in this system originates from secondary pathways
rather than primary nucleation events, and that a lag phase
can originate even in the absence of primary nucleation.SUPPORTING MATERIAL
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